FDA Drug Application (021821) for TYGACIL by PF PRISM CV

Back to FDA Applications sponsored by PF PRISM CV

Application Number021821
Product Number001
FormINJECTABLE;IV (INFUSION)
Dosage50MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameTYGACIL
Active IngredientTIGECYCLINE

Active IngredientCount
List of drugs with Active Ingredient TIGECYCLINE2


Back to FDA Applications sponsored by PF PRISM CV